Valuation: Mayinglong Pharmaceutical Group Co., LTD.

Market Cap 1TCr 147.81Cr 129.29Cr 119.25Cr 110.14Cr 208.99Cr 14TCr 212.5Cr 1.42TCr 559.54Cr 6.94TCr 554.98Cr 542.9Cr 24TCr P/E 2026 *
14.9x
P/E 2027 * 12.4x
Enterprise Value 1TCr 147.81Cr 129.29Cr 119.25Cr 110.14Cr 208.99Cr 14TCr 212.5Cr 1.42TCr 559.54Cr 6.94TCr 554.98Cr 542.9Cr 24TCr EV / Sales 2026 *
2.32x
EV / Sales 2027 * 2.11x
Free-Float
64.65%
Yield 2026 *
-
Yield 2027 * -
1 day-2.31%
1 week+1.66%
Current month+7.54%
1 month-1.61%
3 months-8.68%
6 months-18.16%
Current year-16.96%
1 week 22.52
Extreme 22.52
24.24
1 month 21.22
Extreme 21.22
24.24
Current year 21.22
Extreme 21.22
29.22
1 year 21.22
Extreme 21.22
30.18
3 years 20.2
Extreme 20.2
31.46
5 years 17.99
Extreme 17.99
33.34
10 years 12.52
Extreme 12.52
33.54
Manager TitleAgeSince
Chief Executive Officer 48 28/05/2019
Director of Finance/CFO 49 28/12/2023
Corporate Officer/Principal 40 19/08/2021
Director TitleAgeSince
Chairman 64 16/03/2010
Director/Board Member 48 28/05/2019
Director/Board Member 40 14/06/2022
Change 5-day change 1-year change 3-year change Capi.($)
-2.31%+1.66%-16.16%-13.08% 147.81Cr
-2.33%-2.09%+50.33%+162.29% 1,06000Cr
-0.82%-2.30%+62.97%+61.11% 62TCr
-0.73%-4.98%+27.22%+84.46% 44TCr
+0.33%-1.17%+27.98%+26.90% 33TCr
-0.02%-2.85%+25.27%+44.88% 28TCr
-3.89%-11.22%+20.78%+26.07% 27TCr
+0.66%-1.42%-29.26%-39.30% 22TCr
-0.06%-2.88%+20.98%+61.70% 20TCr
-3.72%-1.10%+13.35%+71.53% 16TCr
Average -1.04%-2.88%+20.35%+48.65% 35.75TCr
Weighted average by Cap. -0.57%-2.96%+35.26%+81.23%

Financials

2026 *2027 *
Net sales 431.8Cr 64Cr 56Cr 51Cr 47Cr 90Cr 6.07TCr 92Cr 613.9Cr 241.08Cr 2.99TCr 239.11Cr 233.91Cr 10TCr 475.4Cr 70Cr 61Cr 57Cr 52Cr 99Cr 6.69TCr 100.8Cr 675.89Cr 265.42Cr 3.29TCr 263.26Cr 257.53Cr 11TCr
Net income 67Cr 9.94Cr 8.69Cr 8.02Cr 7.41Cr 14Cr 948.06Cr 14Cr 96Cr 38Cr 467.04Cr 37Cr 37Cr 1.61TCr 74Cr 11Cr 9.61Cr 8.86Cr 8.19Cr 16Cr 1.05TCr 16Cr 105.92Cr 42Cr 516.24Cr 41Cr 40Cr 1.77TCr
Net Debt - -
Logo Mayinglong Pharmaceutical Group Co., LTD.
Mayinglong Pharmaceutical Group Co Ltd is a China-based company mainly engaged in the production and sale of anorectal health products. The Company operates three segments. The Pharmaceutical Industry segment is mainly engaged in the development, production and sale of pharmaceuticals and health products. The Pharmaceutical Commerce segment is mainly engaged in the retail and wholesale of medical devices and pharmaceuticals. The Hospital Diagnosis and Treatment segment is mainly engaged in hospital medical services and management. The Company mainly conducts businesses within the domestic market.
Employees
2,544
Date Price Change Volume
10/26/10 CN¥23.25 -2.31% 77,08,440
09/26/09 CN¥23.80 +2.28% 97,39,200
08/26/08 CN¥23.27 +2.06% 51,55,200
07/26/07 CN¥22.80 -1.51% 37,76,101
06/26/06 CN¥23.15 +1.22% 51,55,000
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
23.25CNY
Average target price
36.25CNY
Spread / Average Target
+55.91%

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 600993 Stock